
NovoRapid Penfill100 IU/ml
Novo Nordisk
Protamine Crystallised Insulin Aspart is a premixed (biphasic) insulin formulation combining a protamine-crystallized and more.
Protamine Crystallised Insulin Aspart is a premixed (biphasic) insulin formulation combining a protamine-crystallized, intermediate-acting insulin aspart component with a rapid-acting soluble insulin aspart component. It is FDA-approved and widely used for the following indication:
Limitations of use: Protamine Crystallised Insulin Aspart is not recommended for treatment of diabetic ketoacidosis, and because the two components are fixed in a set ratio, the rapid-acting and intermediate-acting portions cannot be dosed independently of one another.
The dose of Protamine Crystallised Insulin Aspart must be individualized based on the patient's metabolic needs, blood glucose monitoring results, and glycemic goals, and adjusted for changes in diet, physical activity, renal or hepatic function, or intercurrent illness.
| Diabetes Type | Typical Regimen |
|---|---|
| Type 1 diabetes | Usually given twice daily, injected within 15 minutes before a meal, individualized to the patient's needs. |
| Type 2 diabetes | Usually given once or twice daily before meals; may be injected up to 15 minutes before or shortly after starting a meal. |
Safety and effectiveness of Protamine Crystallised Insulin Aspart have not been established in pediatric patients; use only under specialist guidance if considered necessary.
Formal pharmacokinetic studies in renal or hepatic impairment have not been conducted for this specific formulation, but insulin requirements may be reduced and the risk of hypoglycemia is increased; more frequent blood glucose monitoring and dose adjustment are recommended (see Use in Special Populations).
The most common and most serious adverse effect of Protamine Crystallised Insulin Aspart is hypoglycemia, which can range from mild to severe and, if untreated, may result in seizure, unconsciousness, or death.
Protamine Crystallised Insulin Aspart is contraindicated in:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.